產(chǎn)品中心您現(xiàn)在的位置:首頁 > 產(chǎn)品展示 > 抗體 > 內(nèi)參抗體 > InVivoMab anti-human PD-1 (CD279)

        InVivoMab anti-human PD-1 (CD279)

        更新時間:2022-01-27

        簡要描述:

        The J116 monoclonal antibody reacts with human PD-1 (programmed death-1) also known as CD279. PD-1 is a 50-55 kDa cell surface receptor encoded by the Pdcd1 gene that belongs to the CD28 family of……

        型號:廠商性質(zhì):代理商瀏覽量:996

        The J116 monoclonal antibody reacts with human PD-1 (programmed death-1) also known as CD279. PD-1 is a 50-55 kDa cell surface receptor encoded by the Pdcd1 gene that belongs to the CD28 family of the Ig superfamily. PD-1 is transiently expressed on CD4 and CD8 thymocytes as well as activated T and B lymphocytes and myeloid cells. PD-1 expression declines after successful elimination of antigen. Additionally, Pdcd1 mRNA is expressed in developing B lymphocytes during the pro-B-cell stage. PD-1's structure includes a ITIM (immunoreceptor tyrosine-based inhibitory motif) suggesting that PD-1 negatively regulates TCR signals. PD-1 signals via binding its two ligands, PD-L1 and PD-L2 both members of the B7 family. Upon ligand binding, PD-1 signaling inhibits T-cell activation, leading to reduced proliferation, cytokine production, and T cell death. Additionally, PD-1 is known to play key roles in peripheral tolerance and prevention of autoimmune disease in mice as PD-1 knockout animals show dilated cardiomyopathy, splenomegaly, and loss of peripheral tolerance. Induced PD-L1 expression is common in many tumors including squamous cell carcinoma, colon adenocarcinoma, and breast adenocarcinoma. PD-L1 overexpression results in increased resistance of tumor cells to CD8 T cell mediated lysis. In mouse models of melanoma, tumor growth can be transiently arrested via treatment with antibodies which block the interaction between PD-L1 and its receptor PD-1. For these reasons anti-PD-1 mediated immunotherapies are currently being explored as cancer treatments. Binding of the J116 antibody is reported to inhibit PD-1 signal transduction, however, it is not reported to block PD-L1 binding.


        產(chǎn)品名稱:InVivoMab anti-human PD-1 (CD279)

        反應種屬:human

        宿主來源:mouse

        實驗應用:in vitro PD-1 neutralization, in vivo PD-1 blockade in humanized mice

        同種型:IgG1, κ

        克隆性:Monoclonal

        克隆號:J116

        產(chǎn)品濃度:Lot specific,typically between 4-11 mg/ml

        保存溫度:Undiluted at 4°C in the dark

        運輸溫度:Ship with adequate amount of blue ice to ensure the product remains at 4°C for the duration of transit

        預期分子量:150 kDa

        產(chǎn)品形式:液體

        有效期:One year from the date of receipt if stored as recommended

        產(chǎn)地:美國



        如需購買或咨詢Bioxcell公司的產(chǎn)品,請聯(lián)系Bioxcell*代理商欣博盛生物


        留言框

        • 產(chǎn)品:

        • 您的單位:

        • 您的姓名:

        • 聯(lián)系電話:

        • 常用郵箱:

        • 省份:

        • 詳細地址:

        • 補充說明:

        • 驗證碼:

          請輸入計算結果(填寫阿拉伯數(shù)字),如:三加四=7
        亚洲AV无码乱码在线观看| 亚洲日韩中文无码久久| 玖玖资源站中文字幕在线| av无码国产在线看免费网站| 亚洲欧美成人久久综合中文网 | 最近免费中文字幕大全免费版视频| 日韩精品久久无码中文字幕| 亚洲中文字幕无码爆乳av中文| 中文字幕在线精品视频入口一区| 国产成人A人亚洲精品无码| 中文字幕av无码一区二区三区电影| 亚洲日韩v无码中文字幕| 中文字幕无码av激情不卡久久| 国产成人无码一区二区在线播放| 亚洲日韩精品一区二区三区无码| 日韩人妻无码精品无码中文字幕| 亚洲一区无码中文字幕| 夜夜精品无码一区二区三区| 国产AV无码专区亚洲AV男同| 无码国产色欲XXXX视频| 亚洲人成无码网站在线观看| 久久久久av无码免费网| 亚洲欧美精品一区久久中文字幕| 欧美视频中文字幕| 人妻少妇精品中文字幕av蜜桃| 久久中文字幕精品| 亚洲午夜AV无码专区在线播放| 本免费AV无码专区一区| 国产成人精品无码片区在线观看| 熟妇无码乱子成人精品| 狠狠躁天天躁无码中文字幕图| 日韩人妻无码精品久久免费一| 亚洲av无码无在线观看红杏| 亚洲AV区无码字幕中文色| 亚洲av无码成人黄网站在线观看| 亚洲av无码专区在线播放 | 亚洲VA中文字幕不卡无码| 亚洲精品无码国产| 无码人妻精品一区二区三区久久久 | 中文字幕在线亚洲精品| 人妻少妇精品中文字幕AV|